Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritis

March 6, 2018, American Academy of Orthopaedic Surgeons

Even with a lack of peer-reviewed evidence, the number of centers advertising stem cell therapies for osteoarthritis (OA) of the knee are increasing in the United States. These centers claim an 80 percent success rate, according to research presented this week at the 2018 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Of the 65 centers that provided pricing information to treat OA of the knee, the cost ranged from $1,150 to $12,000, with an average of $5,000 per injection.

"Our role as is to provide accurate, credible information on options to our patients," said George Muschler, MD, Professor of Orthopaedic Surgery and Director at the Regenerative Medicine Laboratory at Cleveland Clinic. "Recent systematic reviews of cellular therapies for the treatment of knee OA (over 400 papers screened) have found poor levels of evidence for the efficacy of these treatments to date. Current evidence does not justify the rapid rate of growth for these therapies."

Osteoarthritis affects more than 27 million Americans and an estimated 9.9 million adults suffer from OA the knee. Risk factors include age, genetics, being overweight, and repetitive knee bending or heavy lifting.ii Women have an increased risk of osteoarthritis of the knee as they age.ii OA of the knee causes joint pain, stiffness and makes movement difficult.ii

Study details

The researchers contacted 317 U.S. centers that offer direct-to-consumer stem cell musculoskeletal treatments. All communications were via phone or email. The 273 that were successfully contacted were asked for information on same-day stem cell injections for OA of the knee, including clinical efficacy and cost.

Sixty-five centers provided pricing for a same-day stem cell unilateral injection. The mean cost for each therapy was $5,156, with prices varying from $1,150 to $12,000. Fourteen centers charged less than $3,000 and 10 clinics charged more than $8,000 per injection. As insurance doesn't cover stem cell treatments, coverage is paid 100 percent by the patient.

Regarding treatment effectiveness, 36 centers provided data with the mean marketed clinical efficacy of 82.2 percent. Ten clinics claimed 90-100 percent efficacy, 15 claimed 80 to 90 percent efficacy, 10 claimed 70 to 80 percent efficacy and one claimed 55 percent of greater clinical efficacy. The researchers found no correlation between treatment costs and marketed clinical efficacy.

"The claim of "stem cell" carries a high level of expectations for the potential benefits, but research is still many years away from providing clear evidence of effective treatment to patients," said Nicolas S. Piuzzi, MD, lead author and Clinical Scholar in Orthopaedic Regenerative Medicine and Cellular Therapy in the Department of Orthopaedic Surgery at Cleveland Clinic. "As clinicians and researchers, we have ethical, scientific, legal and regulatory concerns. Patients need to be aware of the status of research within the field. If they receive information from anyone offering a treatment claim of an 80 to 100 percent successful recovery, they should be concerned in observance of published peer-reviewed evidence."

Explore further: One-third of costs prior to knee replacement for non-recommended therapies

Related Stories

One-third of costs prior to knee replacement for non-recommended therapies

March 14, 2017
In the year prior to total knee replacement (TKR) surgery, almost one-third of the costs for treatment of arthritis symptoms went toward strategies not recommended by the American Academy of Orthopaedic Surgeons (AAOS), according ...

Weighing nonsurgical treatment options for knee osteoarthritis pain

September 19, 2017
Osteoarthritis (OA) is a progressive "wear and tear" disease of the joint. Osteoarthritis of the knee (knee OA) may not be totally preventable but according to Elizabeth Matzkin, MD, an orthopaedic surgeon specializing in ...

X-rays: The first and best screening tool in diagnosing knee pain among middle-aged patients

September 9, 2016
Knee pain is common among Americans age 40 and up. Nearly 1 in 17 people visit doctors' offices each year for knee pain or injuries from osteoarthritis—a progressive "wear and tear" disease of the joints. Those odds increase ...

AAOS releases guidelines for surgical treatment of osteoarthritis of the knee

December 10, 2015
The American Academy of Orthopaedic Surgeons (AAOS) today introduced a new clinical practice guideline (CPG) for adults undergoing surgery to improve motion and relieve pain caused by osteoarthritis of the knee. The guidelines ...

AAOS Board approves treatment criteria for carpal tunnel syndrome and knee osteoarthritis

December 12, 2016
The American Academy of Orthopaedic Surgeons (AAOS) Board of Directors has approved new Appropriate Use Criteria (AUC) for the management of carpal tunnel syndrome (CTS) and the surgical management of osteoarthritis of the ...

Autologous adipose-derived stromal cells may ease knee OA

June 27, 2016
(HealthDay)—For patients with knee osteoarthritis, a single intra-articular injection of autologous adipose-derived stromal cells (ASCs) can reduce pain and inflammation, according to research published online May 23 in ...

Recommended for you

3-D-printed tracheal splints used in groundbreaking pediatric surgery

September 19, 2018
Children's Healthcare of Atlanta has performed Georgia's first-ever procedure to place 3-D-printed tracheal splints in a pediatric patient. A cross-functional team of Children's surgeons used three custom-made splints, which ...

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Muscle relaxants increase risk of respiratory complications

September 18, 2018
Muscle relaxants are a necessary part of anesthesia during certain major operations. However, studies have hinted at respiratory risks connected with these drugs. POPULAR, a major prospective observational European study ...

Gunshot victims require much more blood and are more likely to die than other trauma patients

September 17, 2018
In a new analysis of data submitted to Maryland's state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times more likely to require blood transfusions, ...

Liver allocation system disadvantages children awaiting transplants

September 17, 2018
Children are at a considerable disadvantage when competing with adults for livers from deceased organ donors in the U.S. allocation system, a University of Pittsburgh Graduate School of Public Health-led analysis reveals ...

Taste preferences connected to success of long-term weight loss after bariatric surgery

September 16, 2018
Following Roux-en-Y gastric bypass (RYGB), a type of bariatric surgery, many patients exhibit a reduction in taste preference for sweet and fatty foods, although this effect may only be temporary, according to new research ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

WebSkipper
not rated yet Mar 06, 2018
Believe it. It's true.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.